Table 1. Impact of TH9402 PDCT on... | American Society of Hematology

Table 1.

Impact of TH9402 PDCT on activated and nonactivated CD4⁺ and CD8⁺ cells evaluated using flow cytometry

Treatment^†	CD4⁺cells (×10⁶ cells)		CD8⁺ cells (×10⁶ cells)
Treatment^†	CD25⁺	CD25⁻	CD25⁺	CD25⁻
Medium	1.68 ± 0.61	0.96 ± 0.69	1.11 ± 0.40	0.50 ± 0.34
TH9402	0.060 ± 0.011	0.21 ± 0.09	0.026 ± 0.012	0.26 ± 0.09

Treatment^†	CD4⁺cells (×10⁶ cells)		CD8⁺ cells (×10⁶ cells)
Treatment^†	CD25⁺	CD25⁻	CD25⁺	CD25⁻
Medium	1.68 ± 0.61	0.96 ± 0.69	1.11 ± 0.40	0.50 ± 0.34
TH9402	0.060 ± 0.011	0.21 ± 0.09	0.026 ± 0.012	0.26 ± 0.09

After exposure to TH9402 PDCT or medium, AB

cells were cultured for 3 days in medium supplemented with IL-2. Absolute cell numbers are expressed in million cells (mean ± SEM of 3 experiments).